| TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis DVF Tauriello, S Palomo-Ponce, D Stork, A Berenguer-Llergo, ... Nature 554 (7693), 538-543, 2018 | 1518 | 2018 |
| Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation A Calon, E Espinet, S Palomo-Ponce, DVF Tauriello, M Iglesias, ... Cancer cell 22 (5), 571-584, 2012 | 1102 | 2012 |
| Stromal gene expression defines poor-prognosis subtypes in colorectal cancer A Calon, E Lonardo, A Berenguer-Llergo, E Espinet, ... Nature genetics 47 (4), 320-329, 2015 | 1064 | 2015 |
| Visualization of a short-range Wnt gradient in the intestinal stem-cell niche HF Farin, I Jordens, MH Mosa, O Basak, J Korving, DVF Tauriello, ... Nature 530 (7590), 340-343, 2016 | 554 | 2016 |
| TGF-beta in CAF-mediated tumor growth and metastasis A Calon, DVF Tauriello, E Batlle Seminars in cancer biology 25, 15-22, 2014 | 374 | 2014 |
| Loss of the tumor suppressor CYLD enhances Wnt/β-catenin signaling through K63-linked ubiquitination of Dvl DVF Tauriello, A Haegebarth, I Kuper, MJ Edelmann, M Henraat, ... Molecular cell 37 (5), 607-619, 2010 | 261 | 2010 |
| Wnt/β-catenin signaling requires interaction of the Dishevelled DEP domain and C terminus with a discontinuous motif in Frizzled DVF Tauriello, I Jordens, K Kirchner, JW Slootstra, T Kruitwagen, ... Proceedings of the National Academy of Sciences 109 (14), E812-E820, 2012 | 260 | 2012 |
| Determinants of metastatic competency in colorectal cancer DVF Tauriello, A Calon, E Lonardo, E Batlle Molecular Oncology, 2017 | 218 | 2017 |
| Overcoming TGFβ-mediated immune evasion in cancer DVF Tauriello, E Sancho, E Batlle Nature Reviews Cancer 22 (1), 25-44, 2022 | 163 | 2022 |
| The various roles of ubiquitin in Wnt pathway regulation DVF Tauriello, MM Maurice Cell cycle 9 (18), 3724-3733, 2010 | 106 | 2010 |
| Targeting the microenvironment in advanced colorectal cancer DVF Tauriello, E Batlle Trends in cancer 2 (9), 495-504, 2016 | 105 | 2016 |
| Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells A Cañellas-Socias, C Cortina, X Hernando-Momblona, S Palomo-Ponce, ... Nature 611, 603-613, 2022 | 68 | 2022 |
| Stromal SOX2 upregulation promotes tumorigenesis through the generation of a SFRP1/2-expressing cancer-associated fibroblast population H Kasashima, A Duran, A Martinez-Ordoñez, Y Nakanishi, H Kinoshita, ... Developmental cell 56 (1), 95-110. e10, 2021 | 63 | 2021 |
| Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy A Alvarez-Varela, L Novellasdemunt, FM Barriga, X Hernando-Momblona, ... Nature Cancer 3 (9), 1052-1070, 2022 | 49 | 2022 |
| TMEM59 potentiates Wnt signaling by promoting signalosome formation JP Gerlach, I Jordens, DVF Tauriello, I van ‘t Land-Kuper, JM Bugter, ... Proceedings of the National Academy of Sciences 115 (17), E3996-E4005, 2018 | 49 | 2018 |
| Simultaneous loss of both atypical protein kinase C genes in the intestinal epithelium drives serrated intestinal cancer by impairing immunosurveillance Y Nakanishi, A Duran, A L’Hermitte, PM Shelton, N Nakanishi, ... Immunity 49 (6), 1132-1147. e7, 2018 | 41 | 2018 |
| Rac1 acts in conjunction with Nedd4 and dishevelled-1 to promote maturation of cell–cell contacts M Nethe, BJ de Kreuk, DVF Tauriello, EC Anthony, B Snoek, T Stumpel, ... Journal of cell science 125 (14), 3430-3442, 2012 | 31 | 2012 |
| Combinatorial immunotherapies for metastatic colorectal cancer E Janssen, B Subtil, F de la Jara Ortiz, HMW Verheul, DVF Tauriello Cancers 12 (7), 1875, 2020 | 28 | 2020 |
| The therapeutic potential of tackling tumor-induced dendritic cell dysfunction in colorectal cancer B Subtil, A Cambi, DVF Tauriello, IJM de Vries Frontiers in Immunology 12, 724883, 2021 | 27 | 2021 |
| Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3-and B7H4-dependent anti-tumor immunity in colorectal cancer K Peuker, A Strigli, DVF Tauriello, A Hendricks, W von Schönfels, ... Immunity 55 (4), 701-717. e7, 2022 | 20 | 2022 |
Eduard BatlleICREA and Oncology Program, Institute for Research in Biomedicine (IRB Barcelona)Verified email at irbbarcelona.org
